Botox USA vs Korea is not a contest with a winner: both countries use botulinum toxin type A, and what really changes is the brand you receive, how the dose is written down and who keeps track of your rounds. For Americans studying or teaching around Hongdae, the practical issue is continuity, because a year in Seoul often means some rounds here and some during visits home. Allergan's Botox is licensed in both countries, while several Korean brands carry approval from Korea's regulator alone. Unit counts compare only within one brand. Effects usually begin within three to five days and fade over roughly three to four months, so the timing of each round matters more than the country it happens in.
Guide
Botox USA vs Korea: what research in Asian faces can tell you
Many Americans in Seoul want to know whether the drug behaves on them the way it did at home. A 2016 report in Toxicon by Wu and colleagues examined the safety and efficacy of onabotulinumtoxinA, the Allergan product, for crow's feet lines in Chinese subjects. Studies in East Asian groups let doctors check, rather than assume, that a product acts as expected in faces with different muscle and skin structure.
A study like that cannot predict your own forehead. Whatever your background, the dose depends on how hard your muscles pull, which the injector judges by watching you frown, lift your brows and squint.
Guide
Switching brands between countries resets the conversation
If you have Botox in the US and are offered a Korean brand in Seoul, you are changing product, not just clinic. Researchers often compare two preparations with a split-face design, where each half of one person's face receives a different product, so age, skin and muscle strength are matched. A 2012 review by Gold in the Yearbook of Dermatology and Dermatologic Surgery discussed a double-blind, split-face proof-of-concept study of two type A preparations for crow's feet.
A controlled comparison in one area does not show that two brands can be swapped at any unit count in every zone. When you switch, expect the dose to be reassessed rather than copied from your last visit.
Guide
What carries over from a US appointment to a Seoul one
A short written log travels further than memory. Before your first round near Hongdae, or before you fly home for one, note the details below and keep them on your phone.
| Detail | Carries over? | Why it matters |
|---|---|---|
| Brand and maker | Yes, if that product is stocked | Botox, Xeomin and Nabota, sold in the US as Jeuveau, exist in both markets |
| Units per area | Only within the same brand | Units are not a shared measure between brands |
| Date of the last round | Always | Rounds placed close together are usually avoided |
| Areas treated | Always | Lets the next injector keep the zones in balance |
| Side effects you had | Always | A past droop or headache changes the plan |
| How long the effect lasted | Always | Shows whether timing, dose or brand needs a rethink |
Guide
Spacing rounds across semesters and flights home
Toxin usually starts working within three to five days, settles at around two weeks and fades over three to four months. Across a year that adds up to three or four rounds, which for students and teachers in Seoul tend to fall between terms and holiday flights.
Hongdae sits on the airport railway, but leave time for a review visit instead of booking injections on your last afternoon.
- Book a Seoul round at least two weeks before a flight home if you want unevenness checked before you leave.
- If a round falls during a visit to the US, decide in advance which injector will do it and bring your log.
- Keep one brand across both countries where you can, so the unit count stays meaningful.
Guide
Risks and reasons to wait, on either side of the Pacific
The common effects do not depend on the country: small bruises, brief tenderness, a mild headache and, less often, a lowered brow or eyelid that recovers as the toxin wears off. Results vary from person to person, and no brand removes these risks.
Postpone treatment if you are pregnant or breastfeeding, have a neuromuscular disorder, an infection or rash where the needle would go, or a past reaction to toxin. Mention blood thinners and any other injectables planned for the same trip.
Evidence
Research behind this page
- Safety and efficacy of onabotulinumtoxinA for the treatment of crow's feet lines in chinese subjectsToxicon · 2016 · doi:10.1016/j.toxicon.2016.11.236
Reported on the safety and efficacy of onabotulinumtoxinA for crow's feet lines in a group of Chinese subjects.
- Comparison of Two Botulinum Toxin Type A Preparations for Treating Crow's Feet: A Split-Face, Double-Blind, Proof-of-Concept StudyYearbook of Dermatology and Dermatologic Surgery · 2012 · doi:10.1016/j.yder.2011.09.011
Yearbook commentary on a double-blind, split-face study that compared two type A toxin preparations for crow's feet.
FAQ
Questions about Botox in Hongdae
If I use Jeuveau at home, can I ask for the same product in Seoul?
Yes, you can ask, because Jeuveau is the US name for Nabota, a toxin made by Daewoong in Korea. Many Korean menus list it under the Nabota name, so mentioning both names avoids confusion. Staying with one product means your previous unit count is a reasonable starting point, although the injector will still watch your expressions before deciding. If the clinic does not stock it, ask which product they suggest instead and expect the dose to be set again.
Can I bring my US dosing notes to a clinic in Hongdae?
Yes, and a clear note helps more than a vague memory of how many units you had. List the brand, the units given to each area, the date and anything that went wrong, such as a heavy brow. A screenshot of an after-visit summary works well. The Seoul injector may still adjust the plan after seeing you move, especially if the brand is different, but the note shows where to begin.
What should I do if the consent form is only in Korean?
Ask for an English version or a spoken explanation before you sign anything you cannot read. The form usually covers the product, the areas treated, common side effects and aftercare, and you should understand each point. A translation app can help with details, but questions about risk are better answered by the doctor directly. If the clinic cannot explain the form in a language you follow, it is reasonable to look elsewhere.
Does a study in Chinese patients apply to me if I am not Asian?
Partly. A study in one population shows how a product performed in that group, and the drug acts the same way on nerve endings in everyone. What differs between people is muscle strength, brow position and skin thickness, and those vary within any background as well as between them. That is why your dose comes from an examination of your face rather than from a trial table or your nationality.
Is it a problem to use one brand in the US and another in Korea?
It is not dangerous in itself, but it makes comparisons harder. Units differ between brands, so a forehead dose that worked with one product cannot be copied to another. If your result fades early or looks different, it becomes hard to tell whether the brand, the dose or the timing caused it. Writing down each product name keeps that question answerable, and telling every injector about the switch lets them plan.